BBNX vs DKNG · rev $100.3M vs rev $6.05B
Beta Bionics, Inc. Common Stock (BBNX) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
DraftKings Inc (DKNG) is a gambling company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported DKNG revenue for 2025-12-31 was $6.05B. Net income was $3.7M. Revenue was up 27.0% from 2024-12-31 to 2025-12-31. DKNG currently screens at market cap $20.96B.
BBNX currently screens at market cap $640.8M. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the BBNX and DKNG stock pages for the full models.
Not investment advice.